The results show that the expression of CDK4 and ANGPTL2 was significantly associated with CNV (Figure 9), indicating that the expression of CDK4 and ANGPTL2 in glioma may be affected by CNV. This evidence concerns the gene ANGPTL2 and central nervous system cancer.